Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivorsResearch in context by Xinyu Liu, Bo Lu, Hao Tang, Xinmiao Jia, Qingyang Zhou, Yanlin Zeng, Xiaoxing Gao, Minjiang Chen, Yan Xu, Mengzhao Wang, Bei Tan, Jingnan Li

Get full text